Zenicor Medical Systems AB is taking a decisive step toward the future of arrhythmia diagnostics by integrating advanced artificial intelligence into its ECG analysis platform. […]
Zenicor Medical Systems has won a competitive procurement contract in the Helsinki region. The company’s ECG solution, Zenicor One, will be used for the investigation […]
The care pathway enables patient assessment in primary care, avoiding unnecessary secondary care referrals. Zenicor One, an easy-to-use thumb ECG, supports timely, accurate diagnosis of […]
The SAFER study, the world’s largest randomized trial of atrial fibrillation screening, has now completed its screening phase, where participants were screened using Zenicor One […]
Zenicor Medical Systems AB has signed an agreement with two university hospitals in Northamptonshire, UK, for the delivery of the Zenicor Solution with Zenicor One […]
In 2024, two thousand people in Värmland will be screened for atrial fibrillation with the Zenicor One for early detection and reduced risk of suffering […]
Stockholm 9 May 2023 Today, the Non-Governmental patient organization The Swedish Heart and Lung Association published a report on Atrial Fibrillation “Flimmerrapporten 2023”. The report […]
Zenicor-ECG successfully used in another mass screening study for atrial fibrillation including 28 000 individuals. The goal of the study is to reduce stroke incidences […]
Zenicor has signed an agreement with a primary care provider in the English National Health Service (NHS) regarding the introduction of a more efficient care […]
Daiichi-Sankyo UK Ltd and Zenicor Medical Systems AB has entered an agreement where Daiichi-Sankyo part-funds a pilot project in which we introduce a new care […]
